Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
CVS Health says its Health100, a CVS Health subsidiary, has received an industry accreditation tied to consumer-facing data privacy and security expectations.
THE APEX TIMES
THE APEX TIMES
A Yahoo Finance market read points to PepsiCo’s lower valuation and a dividend yield above 4% as downside support, while warning that margin stress, higher debt, and softer estimate expectations could limit near-term upside.
THE APEX TIMES
In a market update published late July, PepsiCo said its international growth priorities and brand strategy, backed by productivity efforts, are central to how it expects to perform in 2026. The company also acknowledged that weakness in North America could raise execution risk.
THE APEX TIMES
A Yahoo Finance report ties Exxon Mobil (XOM) to President Donald Trump’s financial disclosures and notes the stock is up roughly 27% year to date. Traders are now asking whether the political connection matters more than cash flows, oil and gas prices, and spending plans.
THE APEX TIMES
Investors are looking for signs of continued momentum at Huntington Ingalls Industries as it prepares to report second-quarter earnings, where sales are expected to rise across segments while higher general and administrative costs could weigh on profit.
THE APEX TIMES
The company denied wrongdoing but agreed to settle claims over consumer notices it sent to shoppers in Washington. A deadline of Aug. 24 applies to people seeking a payment.
THE APEX TIMES
The telecom operator says a new customer-care tool is designed to help callers leave interactions with clearer, documented next steps.
THE APEX TIMES
A recent market comparison frames Walmart’s scale and digital push against Costco’s membership model, suggesting investors are weighing valuation and growth quality as much as retail fundamentals.
THE APEX TIMES
A strong run for Moderna’s stock this year is colliding with lingering skepticism about how quickly the company can convert drug and platform promise into durable financial results.
